Boiron SA (BOI) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Boiron SA (BOI) has a cash flow conversion efficiency ratio of 0.070x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€27.52 Million ≈ $32.17 Million USD) by net assets (€392.78 Million ≈ $459.20 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See BOI equity financing ratio to measure how much of total assets are equity-financed.
Boiron SA - Cash Flow Conversion Efficiency Trend (2001–2025)
This chart illustrates how Boiron SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check BOI cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Boiron SA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Boiron SA ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Kunwu Jiuding Investment Holdings Co Ltd
SHG:600053
|
-0.037x |
|
Cantor Equity Partners IV, Inc. Class A Ordinary Shares
NASDAQ:CEPF
|
0.000x |
|
Hearts and Minds Investments Ltd
AU:HM1
|
-0.012x |
|
Berry Genomics Co Ltd
SHE:000710
|
-0.001x |
|
Fanli Digital Technology Co Ltd
SHG:600228
|
-0.081x |
|
Thor Explorations Ltd.
V:THX
|
0.113x |
|
Shanghai Material Trading Co Ltd A
SHG:600822
|
0.023x |
|
Ways Electron Co Ltd
SHG:605218
|
0.005x |
Annual Cash Flow Conversion Efficiency for Boiron SA (2001–2025)
The table below shows the annual cash flow conversion efficiency of Boiron SA from 2001 to 2025. For the full company profile with market capitalisation and key ratios, see Boiron SA (BOI) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €392.78 Million ≈ $459.20 Million |
€53.24 Million ≈ $62.24 Million |
0.136x | +29.67% |
| 2024-12-31 | €378.18 Million ≈ $442.14 Million |
€39.53 Million ≈ $46.22 Million |
0.105x | -10.04% |
| 2023-12-31 | €391.50 Million ≈ $457.70 Million |
€45.49 Million ≈ $53.18 Million |
0.116x | +10.35% |
| 2022-12-31 | €557.35 Million ≈ $651.60 Million |
€58.69 Million ≈ $68.61 Million |
0.105x | +68.07% |
| 2021-12-31 | €531.77 Million ≈ $621.70 Million |
€33.32 Million ≈ $38.95 Million |
0.063x | -53.27% |
| 2020-12-31 | €509.17 Million ≈ $595.27 Million |
€68.27 Million ≈ $79.81 Million |
0.134x | +33.25% |
| 2019-12-31 | €505.46 Million ≈ $590.94 Million |
€50.86 Million ≈ $59.46 Million |
0.101x | -41.95% |
| 2018-12-31 | €486.04 Million ≈ $568.24 Million |
€84.25 Million ≈ $98.50 Million |
0.173x | -14.36% |
| 2017-12-31 | €517.49 Million ≈ $605.00 Million |
€104.75 Million ≈ $122.46 Million |
0.202x | -13.69% |
| 2016-12-31 | €469.60 Million ≈ $549.01 Million |
€110.13 Million ≈ $128.75 Million |
0.235x | -5.42% |
| 2015-12-31 | €416.04 Million ≈ $486.40 Million |
€103.16 Million ≈ $120.61 Million |
0.248x | -2.04% |
| 2014-12-31 | €379.88 Million ≈ $444.12 Million |
€96.16 Million ≈ $112.42 Million |
0.253x | -7.32% |
| 2013-12-31 | €391.86 Million ≈ $458.12 Million |
€107.02 Million ≈ $125.11 Million |
0.273x | +9.17% |
| 2012-12-31 | €354.16 Million ≈ $414.05 Million |
€88.59 Million ≈ $103.58 Million |
0.250x | +56.78% |
| 2011-12-31 | €368.65 Million ≈ $430.99 Million |
€58.82 Million ≈ $68.77 Million |
0.160x | +6.24% |
| 2010-12-31 | €343.84 Million ≈ $401.99 Million |
€51.64 Million ≈ $60.37 Million |
0.150x | -41.34% |
| 2009-12-31 | €313.28 Million ≈ $366.25 Million |
€80.20 Million ≈ $93.76 Million |
0.256x | +6.15% |
| 2008-12-31 | €271.49 Million ≈ $317.40 Million |
€65.48 Million ≈ $76.55 Million |
0.241x | +7.40% |
| 2007-12-31 | €249.94 Million ≈ $292.21 Million |
€56.13 Million ≈ $65.62 Million |
0.225x | +33.97% |
| 2006-12-31 | €230.09 Million ≈ $268.99 Million |
€38.57 Million ≈ $45.09 Million |
0.168x | -7.68% |
| 2005-12-31 | €229.88 Million ≈ $268.75 Million |
€41.74 Million ≈ $48.80 Million |
0.182x | -23.95% |
| 2004-12-31 | €144.09 Million ≈ $168.46 Million |
€34.40 Million ≈ $40.22 Million |
0.239x | -2.79% |
| 2003-12-31 | €149.53 Million ≈ $174.82 Million |
€36.73 Million ≈ $42.94 Million |
0.246x | -4.17% |
| 2002-12-31 | €134.47 Million ≈ $157.20 Million |
€34.46 Million ≈ $40.29 Million |
0.256x | -8.21% |
| 2001-12-31 | €119.17 Million ≈ $139.32 Million |
€33.27 Million ≈ $38.90 Million |
0.279x | -- |
About Boiron SA
Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products, including medical devices, invitro diagnostics, herbal medicine, food supplements, cosmetics, and CBD-based products. It also provides homeopathic specialties compr… Read more